Recent Patents on Ophthalmic Nanoformulations and Therapeutic Implications
Ann-Marie Ako-Adounvo, Pradeep K. Karla(Howard University), Sai H. S. Boddu(University of Toledo), Xiang Wang, Surajit Dey(University of Tasmania), Laís Camargo de Oliveira
Cited by 47
Related Papers
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
|Pharmaceutics|2018|408
Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
|Molecular Pharmacology|2010|68
Polyamide/Poly(Amino Acid) Polymers for Drug Delivery
|Journal of Functional Biomaterials|2021|65
Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux
|International Journal of Pharmaceutics|2006|59
Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells
|Current Eye Research|2009|57